← Open Payments lookup

QUINCY WALLIS: Open Payments

NPI 1750090429 · OTTAWA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$350 in 19 payments from 15 companies in 2025. Trend: 2023 $28 · 2024 $262 · 2025 $350

Food & beverage: $350
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$69
Grifols USA, LLC1$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31
ABBVIE INC.1$26
Baxter Healthcare1$24
ANI Pharmaceuticals, Inc.1$22
GlaxoSmithKline, LLC.1$21
Viatris Specialty LLC1$20
Tactile Systems Technology Inc1$18
Otsuka America Pharmaceutical, Inc.1$17

Products named: AIRSUPRA, Prolastin-C Liquid, CAPLYTA, VRAYLAR, Hillrom - Vest System Model 205 Acute Care, PURIFIED CORTROPHIN GEL, FASENRA, TRELEGY ELLIPTA.

Industry payments across KS — which companies pay providers there.